Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 11Neoplasms 8Vomiting 6Nausea 5Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain, Postoperative 2Neoplasm, Residual 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms 2Wrist Fractures 1Systemic Inflammatory Response Syndrome 1Supratentorial Neoplasms 1Radicular Cyst 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Mediastinal Neoplasms 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Radiofrequency Ablation 4gadolinium ethoxybenzyl DTPA 2atezolizumab 2Sorafenib 2Oxaliplatin 2Fluorouracil 2Dexmedetomidine 2Bevacizumab 2voxilaprevir 1velpatasvir 1huachansu 1entecavir 1Tobacco Use Cessation Devices 1Tinzaparin 1Telbivudine 1Technetium Tc 99m Aggregated Albumin 1Sofosbuvir 1Sevoflurane 1Ribavirin 1Radionuclide Generators 1Psychiatric Rehabilitation 1Propofol 1Pregabalin 1Polymerase Chain Reaction 1Nivolumab 1Neuroleptanalgesia 1Lamivudine 1Immunotherapy 1Gene Expression Profiling 1Galactose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Liver Neoplasms × Dexamethasone × Clear all
NCT06173466 2025-06-26

Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone

Zhejiang Cancer Hospital

Phase 4 Completed
96 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡